Sessa Capital (Master) L.P. 13D and 13G filings for Provention Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-04-28 4:17 pm Sale | 2023-04-27 | 13G | Provention Bio, Inc. PRVB | Sessa Capital (Master) L.P. | 0 0.000% | -18,403,628 (Position Closed) | Filing |
2023-04-05 08:51 am Purchase | 2023-03-31 | 13G | Provention Bio, Inc. PRVB | Sessa Capital (Master) L.P. | 18,403,628 17.800% | 337,015 (+1.87%) | Filing |
2023-02-14 3:00 pm Purchase | 2022-12-31 | 13G | Provention Bio, Inc. PRVB | Sessa Capital (Master) L.P. | 18,066,613 19.990% | 2,456,443 (+15.74%) | Filing |
2022-07-11 5:29 pm Purchase | 2022-07-07 | 13G | Provention Bio, Inc. PRVB | Sessa Capital (Master) L.P. | 15,610,170 19.990% | 9,714,645 (+164.78%) | Filing |
2022-02-14 5:29 pm Purchase | 2021-12-31 | 13G | Provention Bio, Inc. PRVB | Sessa Capital (Master) L.P. | 5,895,525 9.300% | 5,895,525 (New Position) | Filing |